These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16097091)

  • 61. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
    DerGurahian J
    Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373
    [No Abstract]   [Full Text] [Related]  

  • 62. Drug product liability and health care delivery systems.
    Sage WM
    Stanford Law Rev; 1988 Apr; 40(4):989-1026. PubMed ID: 10318110
    [No Abstract]   [Full Text] [Related]  

  • 63. Trading on traditional medicines.
    Basu P
    Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941
    [No Abstract]   [Full Text] [Related]  

  • 64. What you don't know will hurt you.
    Nat Biotechnol; 2008 Jun; 26(6):589. PubMed ID: 18536658
    [No Abstract]   [Full Text] [Related]  

  • 65. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 66. The FDA animal efficacy rule and biodefense.
    Gronvall GK; Trent D; Borio L; Brey R; Nagao L;
    Nat Biotechnol; 2007 Oct; 25(10):1084-7. PubMed ID: 17921984
    [No Abstract]   [Full Text] [Related]  

  • 67. A strike against preemption.
    Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The FDA and safety--beyond the heparin crisis.
    Laurencin CT; Nair L
    Nat Biotechnol; 2008 Jun; 26(6):621-3. PubMed ID: 18536680
    [No Abstract]   [Full Text] [Related]  

  • 69. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
    Tremaine WJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Re-examining our approach to the approval and use of new drugs.
    Lee SK
    CMAJ; 2006 Jun; 174(13):1855. PubMed ID: 16785460
    [No Abstract]   [Full Text] [Related]  

  • 71. Pharma allowed to make own genetics.
    Owens J
    Nat Rev Drug Discov; 2005 Jul; 4(7):530. PubMed ID: 16075483
    [No Abstract]   [Full Text] [Related]  

  • 72. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 74. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 75. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmaceuticals: online pharmacies: year end report-2002.
    Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-10. PubMed ID: 12856687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities.
    DiMartino LD; Curtis LH; Williams RL; Abernethy DR; Schulman KA
    Food Drug Law J; 2008; 63(4):891-900. PubMed ID: 19601387
    [No Abstract]   [Full Text] [Related]  

  • 78. The international human right to health: what does this mean for our nation and world?
    Kinney ED
    Indiana Law Rev; 2001; 34(4):1457-75. PubMed ID: 16211755
    [No Abstract]   [Full Text] [Related]  

  • 79. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
    Kesselheim AS; Mello MM
    Health Aff (Millwood); 2007; 26(2):483-91. PubMed ID: 17339677
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators: A National Academies Report.
    Gostin LO; Wood AJ; Cuff PA
    JAMA; 2020 Jul; 324(2):145-146. PubMed ID: 32134427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.